GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (MEX:ABT) » Definitions » Cyclically Adjusted Revenue per Share

Abbott Laboratories (MEX:ABT) Cyclically Adjusted Revenue per Share : MXN461.08 (As of Mar. 2025)


View and export this data going back to 1937. Start your Free Trial

What is Abbott Laboratories Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Abbott Laboratories's adjusted revenue per share for the three months ended in Mar. 2025 was MXN121.282. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN461.08 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Abbott Laboratories's average Cyclically Adjusted Revenue Growth Rate was 5.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 2.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Abbott Laboratories was 10.60% per year. The lowest was -1.70% per year. And the median was 7.90% per year.

As of today (2025-06-25), Abbott Laboratories's current stock price is MXN2600.00. Abbott Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was MXN461.08. Abbott Laboratories's Cyclically Adjusted PS Ratio of today is 5.64.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Abbott Laboratories was 8.42. The lowest was 2.19. And the median was 4.96.


Abbott Laboratories Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Abbott Laboratories's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Cyclically Adjusted Revenue per Share Chart

Abbott Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 322.03 372.11 383.37 341.54 464.86

Abbott Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 342.16 408.06 437.15 464.86 461.08

Competitive Comparison of Abbott Laboratories's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Abbott Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Cyclically Adjusted PS Ratio falls into.


;
;

Abbott Laboratories Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abbott Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=121.282/134.9266*134.9266
=121.282

Current CPI (Mar. 2025) = 134.9266.

Abbott Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 53.927 100.684 72.268
201509 57.817 100.392 77.706
201512 59.608 99.792 80.594
201603 56.677 100.470 76.114
201606 66.617 101.688 88.392
201609 69.439 101.861 91.980
201612 74.093 101.863 98.143
201703 68.743 102.862 90.172
201706 68.598 103.349 89.558
201709 70.651 104.136 91.541
201712 84.806 104.011 110.013
201803 76.055 105.290 97.463
201806 86.276 106.317 109.493
201809 80.830 106.507 102.398
201812 85.951 105.998 109.409
201903 82.273 107.251 103.504
201906 86.037 108.070 107.419
201909 89.362 108.329 111.302
201912 88.012 108.420 109.529
202003 101.742 108.902 126.056
202006 94.757 108.767 117.547
202009 109.389 109.815 134.403
202012 118.895 109.897 145.974
202103 119.303 111.754 144.040
202106 113.479 114.631 133.570
202109 125.602 115.734 146.431
202112 132.005 117.630 151.416
202203 133.466 121.301 148.458
202206 128.277 125.017 138.445
202209 118.729 125.227 127.926
202212 112.262 125.222 120.962
202303 100.296 127.348 106.265
202306 97.736 128.729 102.442
202309 101.059 129.860 105.002
202312 99.574 129.419 103.811
202403 94.513 131.776 96.773
202406 108.561 132.554 110.504
202409 119.825 133.029 121.534
202412 131.256 133.157 133.000
202503 121.282 134.927 121.282

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Abbott Laboratories  (MEX:ABT) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Abbott Laboratories's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2600.00/461.08
=5.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Abbott Laboratories was 8.42. The lowest was 2.19. And the median was 4.96.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Abbott Laboratories Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories Business Description

Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.